Vistin Pharma ASA: Dividend of NOK 0.75 per share

health news

Oslo, Norway, 11 January 2024

Norwegian pharmaceutical company Vistin Pharma ASA (“Vistin Pharma”) announced today that the Board has decided for a dividend of NOK 0.75 per share. The dividend is according to the power of attorney given by the annual general meeting on the 22nd of May 2023.

Dividend will be distributed as a repayment of paid-in capital (share premium).

For further information, please contact:

Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.